A smoking cessation program as a resource for bladder cancer patients

Journal of the Canadian Urological Association

Volumn 6, Issue 5, 2012, Pages

  Vilensky, Daniel ^a   Lawrentschuk, Nathan ^a   Hersey, Karen ^a   Fleshner, Neil E ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867906759     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: 10.5489/cuaj.10070     Document Type: Article

References (32)

1. Canadian Cancer Society's Steering Committee: Canadian Cancer Statistics 2009, Toronto. Canadian Cancer Society, 2009. www.cancer.ca/statistics. Accessed April 11, 2011.
2. Cagiannos I, Morash C. Surveillance strategies after definitive therapy of invasive bladder cancer. Can Urol Assoc J 2009;3:S237-42.
3. Ehdaie B, Smith SC, Theodorescu D. Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat. Can Urol Assoc J 2009;3:S232-6.
4. Fradet Y. Screening for bladder cancer: the best opportunity to reduce mortality. Can Urol Assoc J 2009;3:S180-3.
5. Nepple KG, O'Donnell MA. The optimal management of T1 high-grade bladder cancer. Can Urol Assoc J 2009;3:S188-92.
6. Yafi FA, Kassouf W. Radical cystectomy is the treatment of choice for invasive bladder cancer. Can Urol Assoc J 2009;3:409-12.
7. Cohen SM, Johansson SL. Epidemiology and etiology of bladder cancer. Urol Clin North Am 1992;19:421-8.
8. Strope SA, Montie JE. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 2008;180:31-7; discussion 37.
9. Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 2009;104:1436-40.
10. Baris D, Karagas MR, Verrill C, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009;101:1553-61.
11. Nieder AM, MacKinnon JA, Fleming LE, et al. Bladder cancer clusters in Florida: identifying populations at risk. J Urol 2009;182:46-50; discussion 51.
12. Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999;86:2337-45.
13. Kamat AM, Lotan YR. Perioperative Intravesical Therapy after transurethral resection for bladder cancer. J Urol 2010;183:19-20.
14. Lund L, Jacobsen J, Clark P, et al. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: A Danish population-based cohort study. Urology 2010 75:393-8. Epub 2009 Nov 14.
15. Dresler CM, Leon ME, Straif K, et al. Reversal of risk upon quitting smoking. Lancet 2006;368:348-9.
16. Del Rey J, Placer J, Vallmanya F, et al. Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial? BJU Int 2010;106:49-52. Epub 2009 Nov 17.
17. Byrne MM, Davila EP, Zhao W, et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 2010;34:611-7. Epub 2010 Jul 23.
18. Ostroff J, Garland J, Moadel A, et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ 2000;15:86-90.
19. Hay JL, Ostroff J, Burkhalter J, et al. Changes in cancer-related risk perception and smoking across time in newly-diagnosed cancer patients. J Behav Med 2007;30:131-42.
20. Nieder AM, John S, Messina CR, et al. Are patients aware of the association between smoking and bladder cancer? J Urol 2006;176:2405-8; discussion 2408.
21. Dearing J. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 2005;87:85-7.
22. Centers for Disease Control and Prevention (USA). Behavioral Risk Factor Surveillance System Questionnaire; December 31, 2007.
23. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38-48.
24. Lotan Y, Elias K, Svatek RS, et al. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker. J Urol 2009;182:52-7; discussion 58.
25. Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352-8.
26. Logan HL, Fillingim RB, Bartoshuk LM, et al. Smoking status and pain level among head and neck cancer patients. J Pain 2010;11:528-34.
27. Cowling DW, Yang J. Smoking-attributable cancer mortality in California, 1979-2005. Tob Control 2010;19 (Suppl 1):i62-7.
28. Canadian Cancer Society. One Step at a Time. http://www.cancer.ca/Ontario/Publications.aspx?sc_ lang=en. Accessed April 11, 2011.
29. Velicer W, Prochaska J, Fava J, et al. Smoking cessation and stress management: applications of the transtheoretical model of behavior change. Homeostasis 1998;38.
30. Coleman T. ABC of smoking cessation. Use of simple advice and behavioural support. BMJ 2004;328:397-9.
31. Ministry of Health and Long Term Care (Ontario-Canada). The Ottawa Model for Smoking Cessation, a network's success: simply smoke free. http://www.health.gov.on.ca/english/providers/program/ cdpm/pdf/ottawa.pdf. Accessed April 11, 2011.
32. Ministry of Health Promotion. (Ontario-Canada). News Release: McGuinty Government Supports Innovative Smoking Cessation Program. http://www.mhp.gov.on.ca/en/news/2005/110905.asp. Accessed April 11, 2011.